500k kidney patients families pay $600 mthly dialysis, U considered vote PAP out?
4 Articles
4 Articles
Arch advancing game-changing therapies for global kidney care - BioTuesdays
By Melane Sampson Richard Muruve, CEO of Arch Arch Biopartners (TXSV:ARCH; QTCQB:ACHFF) is at the forefront of developing breakthrough therapies to combat acute kidney injury (AKI) and prevent organ damage. By targeting the dipeptidase-1 (DPEP1) inflammation pathway—an overlooked yet critical driver of kidney and multi-organ inflammation—Arch is advancing a platform of novel drugs with the potential to transform treatment for millions of patien…


Renacare: Five Years of Transforming Kidney Care
Noida (Uttar Pradesh) [India], April 14: Renacare Dialysis, under the mentorship of Dr. Anil Prasad Bhatt, the Founder, is celebrating its fifth anniversary in 2025, coinciding with the World Health Day on 7th April. This milestone reflects their growth from a startup launched during the COVID lockdown in 2020 to one of the most trusted […] The post Renacare: Five Years of Transforming Kidney Care appeared first on Up18 News.
500k kidney patients families pay $600 mthly dialysis, U considered vote PAP out?
If 500k kidney patients families paying $600 monthly for dialysis, you should consider vote PAP out, right? Demanding for FREE dialysis like other advanced countries. Think again, paying $7,200 a year is a lot of money (no cure) and over one's whole lifetime . Any comments.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage